/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in four segments: Established Pharmaceutical Products; Diagnostic Products; Nutritional Products; and Medical Devices. Based in North Chicago, Illinois, ABT is expected to unveil its fiscal Q1 2025 earnings results before the market opens on Wednesday, Apr. 16.
Ahead of this event, analysts expect the company to report a profit of $1.07 per share, up 9.2% from $0.98 per share in the year-ago quarter. The company has surpassed or met Wall Street's earnings estimates in the last four quarters. In Q4 2024, ABT met the consensus EPS estimate.